SM
CELL

SG3 Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

SG3 Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,400
Closed -$47K – 1356
2021
Q3 		$47K Buy
+2,400
New +$91.3K ﹤0.01% 913

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

SG3 Management's CELL Position: Q1 2022 in Review

SG3 Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 22,500 shares — an estimated $409K sold.

SG3 Management first reported a position in CELL in Q4 2021 and held it in 1 quarter. The position peaked at $409K in Q4 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • SG3 Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • SG3 Management sold 22,500 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $409K.
  • SG3 Management first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • SG3 Management's PhenomeX Inc. Common Stock position peaked at $409K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.